PCSK9 and atrial fibrillation: In conclusion, we demonstrated for the first time that PCSK9, at a concentration commonly found in the human circulation of AF patients, directly induces CD36-mediated platelet activation by amplifying Nox2 activity: this effect is amplified in the presence of LDL (Graphical Abstract).